Abpro Holdings (ABPO) Current Assets (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Current Assets came in at $6.7 million in Q1 2026, up 201.98% YoY from $2.2 million in Q1 2025, and up 647.88% on a QoQ basis from $896000.0 in Q4 2025.
Abpro Holdings (ABPO) Current Assets (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Current Assets data on file, last reported at $6.7 million in Q1 2026.
- Quarterly Current Assets rose 201.98% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 201.98% YoY) and the FY2025 annual result came in at $896000.0, down 76.27% from the prior year.
- Current Assets advanced to $6.7 million in Q1 2026, from $896000.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $6.7 million in Q1 2026 to a low of $25756.0 in Q1 2024.
- A 5-year average of $1.7 million and a median of $1.1 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets sank 95.5% — and 2025, when it soared 8515.47%.
- Tracing ABPO's Current Assets over 5 years: stood at $770226.0 in 2022, then soared by 164.21% to $2.0 million in 2023, then soared by 85.55% to $3.8 million in 2024, then sank by 76.27% to $896000.0 in 2025, then surged by 647.88% to $6.7 million in 2026.
- The last three Current Assets figures came in at $6.7 million (Q1 2026), $896000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.76 Bn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | 5.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.70 Mn |
| Dec 31, 2025 | 896,000.00 |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 3.78 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 277,279.00 |
| Mar 31, 2024 | 25,756.00 |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 572,433.00 |
| Dec 31, 2022 | 770,226.00 |
| Sep 30, 2022 | 678,966.00 |
| Jun 30, 2022 | 904,987.00 |
| Mar 31, 2022 | 1.07 Mn |